相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Scientific rationale for the development of gene therapy strategies for Parkinson's disease
Tomas Bjorklund et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model
Ana Munoz et al.
EXPERIMENTAL NEUROLOGY (2009)
Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats
Tomas Bjorklund et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Positron Emission Tomography Imaging Demonstrates Correlation between Behavioral Recovery and Correction of Dopamine Neurotransmission after Gene Therapy
Ludovic Leriche et al.
JOURNAL OF NEUROSCIENCE (2009)
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice
Linan Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat
Sharon Reimsnider et al.
MOLECULAR THERAPY (2007)
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease
Thomas Carlsson et al.
JOURNAL OF NEUROSCIENCE (2007)
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats
Manolo Carta et al.
BRAIN (2007)
The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease
Nathalie Breysse et al.
JOURNAL OF NEUROSCIENCE (2007)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
P Piccini et al.
BRAIN (2005)
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease - A clinical and pharmacokinetic study
F Stocchi et al.
ARCHIVES OF NEUROLOGY (2005)
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors
T Carlsson et al.
BRAIN (2005)
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
S Zolotukhin et al.
METHODS (2002)
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
F Stocchi et al.
BRAIN (2002)
L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease:: Relation to motor and cellular parameters of nigrostriatal function
C Winkler et al.
NEUROBIOLOGY OF DISEASE (2002)
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Chemical neuroanatomy of the basal ganglia - normal and in Parkinson's disease
O Hornykiewicz
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
D Kirik et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat
M Romero-Ramos et al.
MOLECULAR BRAIN RESEARCH (2000)
The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier
T Kageyama et al.
BRAIN RESEARCH (2000)
Continuous dopamine-receptor stimulation in advanced Parkinson's disease
JG Nutt et al.
TRENDS IN NEUROSCIENCES (2000)
Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis
AM Graybiel et al.
TRENDS IN NEUROSCIENCES (2000)
A measure of striatal function predicts motor stereotypy
JJ Canales et al.
NATURE NEUROSCIENCE (2000)
分享论文
